The current status of CLL treatment and how clinical practice will change
Understanding why CLL patients stop responding to treatment, and options for salvage therapies
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?
How combining an evolutionary perspective with genomic methods can advance CLL treatment
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting